MICHELLE MARTIN: Open Payments
NPI 1750017604 · FAIRMONT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 64 payments from 12 companies in 2025. Trend: 2023 $1,470 · 2024 $1,872 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $427 |
| Otsuka America Pharmaceutical, Inc. | 10 | $198 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Alkermes, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Janssen Pharmaceuticals, Inc | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
Products named: VRAYLAR, REXULTI, INGREZZA, AUSTEDO XR, ARISTADA, TRINTELLIX, CAPLYTA, SPRAVATO.
Industry payments across WV — which companies pay providers there.
